Skip to content

A Study Exploring Brain Activity in Relation to Sensory Arm Impairments in the Early Stages of Stroke

Neural Correlates of Upper Limb Somatosensory Impairments and Recovery in the Acute Phase After Stroke: an EEG Investigation

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03407547
Enrollment
20
Registered
2018-01-23
Start date
2018-11-01
Completion date
2025-12-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

upper limb, recovery, somatosensory, impairment, electroencephalography, acute phase

Brief summary

This clinical study is organized for people with stroke often experience difficulties with their sensation in their upper limb. New technologies may be able to help these important problems. However, there is currently not enough knowledge about how the brain recovers in people with sensory impairments in their arm and hand. Using a non-invasive technique of recording brain activity, known as electroencephalography (EEG), brain activity in combination with somatosensation of the hand will be measured. Therefore, the purpose of this study will be to analyse brain activity in relation to somatosensory impairments after stroke during the first two weeks after stroke.

Interventions

DIAGNOSTIC_TESTElectroencephalography

EEG is a device to measure brain activity via surface electrodes

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Participants will be recruited during the first 2-3 days post-stroke. They should have: 1. a first-ever unilateral, supra-tentorial stroke, as defined by Wold Health Organisation; 2. admission to the acute hospital, 3. deficit in distal pinprick somatosensory measured by Rivermead assessment of somatosensory performance (score of ≤4) and/or motor impairment measured by Fugl Meyer Assessment (score of ≤12 out of 14), 4. the age of \> 18 years and 5. the ability to provide informed consent. Healthy adults will also be recruited and they should have: 1. no history of sensory impairments in their hands 2. the age of \> 18 years and 3. the ability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Sensory Evoked Potential LatencyFirst 2 weeks post-strokeEEG measurement
Sensory Evoked Potential AmplitudeFirst 2 weeks post-strokeEEG measurement

Secondary

MeasureTime frameDescription
Perceptual Threshold of TouchFirst 2 weeks post-strokeLight touch of the palmar surface of index finger
Erasmus modified Nottingham Sensory AssessmentFirst 2 weeks post-strokeMeasures somatosensation of the upper limb and hand
Fugl Meyer AssessmentFirst 2 weeks post-strokeUpper limb motor impairment measurement
Montreal Cognitive AssessmentFirst 2 weeks post-strokeMeasures cognition
Nottingham Sensory AssessmentFirst 2 weeks post-strokeMeasures stereognosis
Wolf Motor Function TestFirst 2 weeks post-strokeUpper limb activities measurement

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026